← Cases
United KingdomHealthcare and life sciences2025 – ongoing

Benenden Health

SkinVision skin-cancer risk assessments for members

Benenden Health made AI skin assessments available to 870,000+ members

In progressCompany's own claimOfficial ↗

Problem

Members could struggle to recognize early signs of skin cancer. Benenden Health wanted to provide convenient access to skin assessments and onward support.

Approach

Benenden Health partnered with SkinVision in December 2025 and made the service immediately available to members. SkinVision combined AI analysis of photographs of moles and skin spots with dermatologist expertise to assess cancer risk. Members could share assessments with their doctor.

Results

870,000+members eligible for immediate access, according to Benenden Health; not a user countCompany's own claim[1]

Takeaway

The rollout expanded access to risk assessments. Benenden Health did not report member uptake or clinical outcomes from the partnership.

Categories

Business function
Production and quality
AI technology
Computer vision
Evidence
Company's own claim

Sources

Source summaries

[1]Benenden Health1 Dec 2025

Benenden Health announced immediate access to SkinVision for its membership. It described AI photo analysis supported by dermatologists, without reporting results from Benenden members.

Full details are in the original sources.

Added 1 Nov 2026 · Updated 1 Nov 2026
Open case page ↗